The American Diabetes Association Launches Collaborative Oral Health Campaign with Pacific Dental Services

Today, the American Diabetes Association® (ADA) announced a collaborative Oral Health campaign with Pacific Dental Services (PDS), one of the country’s leading dental support organizations. The campaign aims to increase awareness of the link between periodontal disease (gum disease) and diabetes and how oral health providers can assist patients in preventing and managing this chronic health condition.

Over 37 million Americans live with diabetes today, and 1 in 5 people don’t know they have it. Diabetes can affect every part of the body, including the mouth. In fact, oral health issues are sometimes the first sign that a person has diabetes or prediabetes.

Dental care is an important part of a diabetes management plan, as there is a two-way link between oral health and diabetes—meaning that high blood glucose (blood sugar) affects oral health, while gum disease affects how well you can manage your blood glucose levels.

Having diabetes can increase the amount of glucose in your saliva, and it can cause your mouth to produce less saliva, which lessens your mouth’s ability to wash away food particles and keep the area moist. Both can lead to an increased risk of developing gum disease. And if you already have gum disease, your gums can become inflamed. Studies show that inflammation in the body can increase blood glucose levels, thus increasing your risk of developing diabetes or, if you have it, making it harder to manage.

It’s important to include a dentist as part of your health care team so they can address gum disease early and advise on how to keep your mouth healthy—whether you have diabetes or are looking to prevent it. A dentist can even spot the warning signs of diabetes during your annual oral exam, but only a doctor can officially diagnose you with a blood test.

“Oral health is the window to the entire body, and nearly 1 in 5 people with severe gum disease were suspected of having type 2 diabetes and not knowing it,” said Charles D. Henderson, chief executive officer for the American Diabetes Association. “Dental care is vital in order to successfully manage diabetes. Your dentist is an essential member of your health care team. We hope this collaboration brings awareness and education to people living with diabetes, so they can improve their overall health.”

“Pacific Dental Services is proud to be a leading voice in advocating for closer collaboration between medical and dental professionals in order to improve systemic health outcomes for patients,” said Stephen E. Thorne IV, Founder and CEO of Pacific Dental Services. “Due to the bi-directional relationship of periodontal disease and diabetes, oral health care providers can truly make a difference in preventing and managing the disease. We are proud to partner with the American Diabetes Association in this effort to educate patients on the connection between their oral health and overall wellbeing.”

This Oral Health campaign will promote educational materials and resources related to diabetes and oral care on the ADA’s website, including articles, daily health tips, social media posts, and more. Take the ADA’s 60-Second Type 2 Diabetes Risk Test today and receive the next steps to managing your risk.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”